Understanding the Basics of Study Design
A promising research question can still produce inconclusive results if the population, intervention, comparator, endpoints, and analysis approach don’t fit
A promising research question can still produce inconclusive results if the population, intervention, comparator, endpoints, and analysis approach don’t fit
Aligning Institutional Policy With System Updates: A Practical Guide Keep institutional policies, research administration workflows, and technology aligned as your
Discover how Recursion partnered with Advarra to bring operational evidence into protocol design, uncovering potential enrollment risks, assessment burden, and
Meeting Sites Where They Are: A Connected, Intelligence-Powered Operating Model This on-demand webinar, presented by ICON, Advarra, and Fierce Pharma,
Clinical trial study startup has become increasingly technology-enabled, yet sponsors, contract research organizations (CROs), and research sites still face persistent
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger
Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites, and institutional review boards (IRBs).
Clinical research increasingly depends on electronic systems to support core trial documentation, data handling, and regulated workflows. That shift has
Unlocking Unstructured Data with AI for Optimized Protocol Development In this podcast episode, Mike Eckrote, Senior Vice President of Strategic
How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions Choosing the right sites can
IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight process. For sponsors, approval marks
Heading to the Advarra Innovation Summit in London? Share the news and encourage your peers and partners to join you!